What's new at Łukasiewicz – PORT?
- Czas czytania: 3 min
The Biobank Research Group has increased its biological sample collection by 500%, enabling the Population Diagnostics Center, led by Dr. hab. Patrycja Gazińska, to reach a key milestone in the P4Health project funded under Teaming for Excellence.
- Czas czytania: 3 min
From May 18 to 21, 2027, Wrocław will host the 12th International γδ T Cell Conference, a leading global meeting for researchers studying γδ T cells – immune cells with tremendous therapeutic potential.
- Czas czytania: 3 min
The Virtual Research Institute (WIB), operating within the structure of Łukasiewicz – PORT, is seeking partners for the commercialization of an innovative mRNA-based technology. The technology was developed by one of WIB’s research teams, and we are looking for a partner to help further develop and bring it to market.
- Czas czytania: 3 min
“If I had to choose one word that is essential for the future of oncology, I would say: connections,” said Prof. Stefaan van Gool at PORT for Health: Oncology 2026. Participants agreed that the future lies in combination therapies, precision medicine, and close collaboration between research and clinical practice.
- Czas czytania: 3 min
Prof. Bastian Hengerer, Director of the P4Health Center, talks about his vision for the center, translating scientific discoveries into solutions for patients, and management based on trust.
- Czas czytania: 5 min
Glioblastoma is one of the most formidable challenges in modern oncology—a cancer that often evades both conventional treatments and advanced immunotherapies. In the SelCell project, scientists at the Łukasiewicz – PORT are exploring a new strategy based on gamma-delta T lymphocytes. Their goal is to understand why immune cells from some donors can destroy tumor cells far more effectively than those from others.
- Czas czytania: 3 min
Dr. Valentina Mosienko from the University of Bristol will speak on June 11 about how stress affects brain function and the role glial cells may play in emotional regulation and the action of antidepressant drugs.
- Czas czytania: 3 min
Precision medicine is transforming diagnosis and treatment, requiring advanced molecular analysis, deep insight into disease mechanisms, and high-quality biological samples, making close collaboration between researchers, laboratories, and hospitals essential for implementing innovative therapies.
- Czas czytania: 3 min
On 1–2 June 2026, Brussels will host “From Ideas to Impact: Emerging Health Technologies in Action” – a two-day event dedicated to health innovation, international collaboration, and building project partnerships within European research and innovation initiatives.
- Czas czytania: 3 min
Disruptions in energy metabolism are increasingly linked to the development of neurodegenerative diseases. Research by Dr. Ismail Gbadamosi shows how TDP-43 and energy imbalance influence motor neuron vulnerability in ALS, opening the way to new therapeutic strategies.
